Conditional Deletion of Smad1 and Smad5 in Somatic Cells of Male and Female Gonads Leads to Metastatic Tumor Development in Mice

ABSTRACT The transforming growth factor β (TGFβ) family has critical roles in the regulation of fertility. In addition, the pathogenesis of some human cancers is attributed to misregulation of TGFβ function and SMAD2 or SMAD4 mutations. There are limited mouse models for the BMP signaling SMADs (BR-SMADs) 1, 5, and 8 because of embryonic lethality and suspected genetic redundancy. Using tissue-specific ablation in mice, we deleted the BR-SMADs from somatic cells of ovaries and testes. Single conditional knockouts for Smad1 or Smad5 or mice homozygous null for Smad8 are viable and fertile. Female double Smad1 Smad5 and triple Smad1 Smad5 Smad8 conditional knockout mice become infertile and develop metastatic granulosa cell tumors. Male double Smad1 Smad5 conditional knockout mice are fertile but demonstrate metastatic testicular tumor development. Microarray analysis indicated significant alterations in expression of genes related to the TGFβ pathway, as well as genes involved in infertility and extracellular matrix production. These data strongly implicate the BR-SMADs as part of a critical developmental pathway in ovaries and testis that, when disrupted, leads to malignant transformation.

[1]  E. Fearon,et al.  Cancer progression , 1999, Current Biology.

[2]  H. Friess,et al.  Induction and expression of betaig-h3 in pancreatic cancer cells. , 2002, Biochimica et biophysica acta.

[3]  S. Thiagalingam,et al.  Elucidation of Epigenetic Inactivation of SMAD8 in Cancer Using Targeted Expressed Gene Display , 2004, Cancer Research.

[4]  Y. Okada,et al.  Misexpression of full-length HMGA2 induces benign mesenchymal tumors in mice. , 2006, Cancer research.

[5]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[6]  G. Hammer,et al.  Genetic removal of Smad3 from inhibin-null mice attenuates tumor progression by uncoupling extracellular mitogenic signals from the cell cycle machinery. , 2007, Molecular endocrinology.

[7]  A. Durlinger,et al.  Printed in U.S.A. Copyright © 1999 by The Endocrine Society Control of Primordial Follicle Recruitment by Anti-Müllerian Hormone in the Mouse Ovary* , 2022 .

[8]  A. Bradley,et al.  α-lnhibin is a tumour-suppressor gene with gonadal specificity in mice , 1992, Nature.

[9]  K. Miyazono,et al.  BMP signals inhibit proliferation and in vivo tumor growth of androgen-insensitive prostate carcinoma cells , 2004, Oncogene.

[10]  S. Karlsson,et al.  Smad5 is dispensable for adult murine hematopoiesis. , 2006, Blood.

[11]  L. Wakefield,et al.  The two faces of transforming growth factor β in carcinogenesis , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[12]  M. Matzuk,et al.  Genetic Analysis of the Mammalian Transforming Growth Factor-β Superfamily , 2002 .

[13]  R L Vessella,et al.  Bone morphogenetic protein signaling in prostate cancer cell lines , 2004, Journal of cellular biochemistry.

[14]  J. Graff,et al.  SMAD3 regulates gonadal tumorigenesis. , 2007, Molecular endocrinology.

[15]  Andy J. Minn,et al.  Genes that mediate breast cancer metastasis to lung , 2005, Nature.

[16]  R. Behringer,et al.  Misregulated Wnt/beta-catenin signaling leads to ovarian granulosa cell tumor development. , 2005, Cancer research.

[17]  Ossama Tawfik,et al.  BMP signaling inhibits intestinal stem cell self-renewal through suppression of Wnt–β-catenin signaling , 2004, Nature Genetics.

[18]  K. Miyazono,et al.  BMP receptor signaling: transcriptional targets, regulation of signals, and signaling cross-talk. , 2005, Cytokine & growth factor reviews.

[19]  J. Massagué,et al.  TGFbeta signaling in growth control, cancer, and heritable disorders. , 2000, Cell.

[20]  A. Moustakas,et al.  Actions of TGF-β as tumor suppressor and pro-metastatic factor in human cancer , 2007 .

[21]  C. Heldin,et al.  Id2 and Id3 Define the Potency of Cell Proliferation and Differentiation Responses to Transforming Growth Factor β and Bone Morphogenetic Protein , 2004, Molecular and Cellular Biology.

[22]  R. Behringer,et al.  Cell-specific knockout of steroidogenic factor 1 reveals its essential roles in gonadal function. , 2004, Molecular endocrinology.

[23]  A. Moustakas,et al.  Actions of TGF-beta as tumor suppressor and pro-metastatic factor in human cancer. , 2007, Biochimica et biophysica acta.

[24]  J. Massagué,et al.  Smad transcription factors. , 2005, Genes & development.

[25]  Brad T. Sherman,et al.  DAVID: Database for Annotation, Visualization, and Integrated Discovery , 2003, Genome Biology.

[26]  H. Friess,et al.  Induction and expression of βig-h3 in pancreatic cancer cells , 2002 .

[27]  R. Behringer,et al.  Requirement of Bmpr1a for Müllerian duct regression during male sexual development , 2002, Nature Genetics.

[28]  J. Carethers,et al.  Bone morphogenetic protein signaling and growth suppression in colon cancer. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[29]  Martin M Matzuk,et al.  Intraovarian activins are required for female fertility. , 2007, Molecular endocrinology.

[30]  E. Bikoff,et al.  Dose-dependent Smad1, Smad5 and Smad8 signaling in the early mouse embryo. , 2006, Developmental biology.

[31]  T. Wagner,et al.  Targeted overexpression of luteinizing hormone in transgenic mice leads to infertility, polycystic ovaries, and ovarian tumors. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[32]  E. Robertson,et al.  Mouse embryos lacking Smad1 signals display defects in extra-embryonic tissues and germ cell formation. , 2001, Development.

[33]  M. Matzuk,et al.  Smad5 knockout mice die at mid-gestation due to multiple embryonic and extraembryonic defects. , 1999, Development.

[34]  M. Piver,et al.  Metastatic patterns in histologic variants of ovarian cancer. An autopsy study , 1989, Cancer.

[35]  G. Broggi,et al.  Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells , 2006, Nature.

[36]  Victor E. Velculescu,et al.  Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis , 2001, Nature Genetics.

[37]  F. Pouliot,et al.  Role of Smad1 and Smad4 proteins in the induction of p21WAF1,Cip1 during bone morphogenetic protein-induced growth arrest in human breast cancer cells. , 2002, The Journal of endocrinology.

[38]  Howard Y. Chang,et al.  Bone morphogenetic protein antagonist gremlin 1 is widely expressed by cancer-associated stromal cells and can promote tumor cell proliferation , 2006, Proceedings of the National Academy of Sciences.

[39]  A. Fusco,et al.  Nuclear phosphoproteins HMGA and their relationship with chromatin structure and cancer , 2004, FEBS letters.

[40]  R. Derynck,et al.  SPECIFICITY AND VERSATILITY IN TGF-β SIGNALING THROUGH SMADS , 2005 .

[41]  P. Donahoe,et al.  Müllerian inhibiting substance regulates its receptor/SMAD signaling and causes mesenchymal transition of the coelomic epithelial cells early in Müllerian duct regression , 2006, Development.

[42]  A. Bradley,et al.  Activin signaling through activin receptor type II causes the cachexia-like symptoms in inhibin-deficient mice. , 1996, Molecular endocrinology.

[43]  M. Matzuk,et al.  Granulosa cell-specific inactivation of follistatin causes female fertility defects. , 2004, Molecular endocrinology.

[44]  M. Matzuk,et al.  Growth Differentiation Factor 9 Regulates Expression of the Bone Morphogenetic Protein Antagonist Gremlin* , 2004, Journal of Biological Chemistry.

[45]  L. Wakefield,et al.  The two faces of transforming growth factor beta in carcinogenesis. , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[46]  Wei Zhang,et al.  Profiling of differentially expressed genes in human primary cervical cancer by complementary DNA expression array. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[47]  L. David,et al.  Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells. , 2007, Blood.

[48]  J. Kench,et al.  Loss of BMP2, Smad8, and Smad4 expression in prostate cancer progression , 2004, The Prostate.

[49]  D. Huylebroeck,et al.  Generation of a floxed allele of Smad5 for cre‐mediated conditional knockout in the mouse , 2003, Genesis.

[50]  M. Matzuk,et al.  Premature luteinization and cumulus cell defects in ovarian-specific Smad4 knockout mice. , 2006, Molecular endocrinology.

[51]  K. Kinzler,et al.  Secreted and cell surface genes expressed in benign and malignant colorectal tumors. , 2001, Cancer research.

[52]  P. Steeg.  Tumor metastasis: mechanistic insights and clinical challenges , 2006, Nature Medicine.

[53]  D. Montell,et al.  Ovarian Cancer Metastasis: Integrating insights from disparate model organisms , 2005, Nature Reviews Cancer.

[54]  A. Roberts,et al.  Conditional knockout of the Smad1 gene , 2002, Genesis.

[55]  W. Bodmer,et al.  Screening SMAD1,SMAD2, SMAD3, andSMAD5 for germline mutations in juvenile polyposis syndrome , 1999, Gut.

[56]  R. Kalluri,et al.  BMP-7 counteracts TGF-β1–induced epithelial-to-mesenchymal transition and reverses chronic renal injury , 2003, Nature Medicine.

[57]  A. Balmain,et al.  TGF-beta signaling in tumor suppression and cancer progression. , 2001, Nature genetics.

[58]  M. Goumans,et al.  Balancing the activation state of the endothelium via two distinct TGF‐β type I receptors , 2002, The EMBO journal.

[59]  C. Harris,et al.  hSmad5 gene, a human hSmad family member: its full length cDNA, genomic structure, promoter region and mutation analysis in human tumors , 1998, Oncogene.

[60]  R. Derynck,et al.  Specificity and versatility in tgf-beta signaling through Smads. , 2005, Annual review of cell and developmental biology.

[61]  K. Franssila,et al.  Familial juvenile polyposis coli; increased risk of colorectal cancer. , 1984, Gut.